Guidelines accompanied by changes in reimbursement rules Effects on lipid-lowering drug prescribing.
Objective - To analyse the effect of guidelines accompanied by changes in reimbursement rules for the prescription of lipid-lowering drugs (LLDs). Design - Observational study focusing on LLD use before (1994- 98) and after an intervention (1999). Setting - Guidelines were developed by the Danish Co...
| Publicado en: | Scandinavian Journal of Primary Health Care Vol. 19; no. 3; pp. 158 - 163 |
|---|---|
| Autores principales: | , , |
| Formato: | Journal Article |
| Publicado: |
Taylor & Francis Ltd
Sep2001
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106094289&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106094289 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 02813432 BDB jtl: Scandinavian Journal of Primary Health Care issn: 02813432 maglogo: Y pubinfo: dt: Sep2001 vid: 19 iid: 3 pid: 377 pub: Taylor & Francis Ltd place: Philadelphia, Pennsylvania artinfo: ui: 106094289 106094289 2009437839 10.1080/028134301316982379 NLM11697556 106094289 ppf: 158 ppct: 5 formats: fmt: @attributes: type: P tig: atl: Guidelines accompanied by changes in reimbursement rules Effects on lipid-lowering drug prescribing. aug: au: Bjerrum L Larsen J Kragstrup J sug: subj: Antilipemic Agents Therapeutic Use Drug Utilization Statistics and Numerical Data Practice Guidelines Reimbursement Mechanisms Statistics and Numerical Data Aged Coronary Disease Etiology Coronary Disease Prevention and Control Denmark Female Male Middle Age Aged: 65+ years Middle Aged: 45-64 years Female Male ab: Objective - To analyse the effect of guidelines accompanied by changes in reimbursement rules for the prescription of lipid-lowering drugs (LLDs). Design - Observational study focusing on LLD use before (1994- 98) and after an intervention (1999). Setting - Guidelines were developed by the Danish College of General Practitioners and focused on prevention of cardiovascular heart disease (CHD). Guidelines were sent out and changes in reimbursement took place in December 1998. Prescriptions for LLDs were extracted from a population-based prescription database (Odense University Pharmacoepidemiological Database, OPED) covering 10% of the Danish population (470 000 inhabitants). Main outcome measures - Incidence rate and 1 year prevalence rate (annual prevalence) of LLD use. Results - The incidence of LLD use increased significantly in the year following the intervention. Incidence rate ratio (after/before) was 1.43 (CI 1.35-1.52). The annual prevalence of LLD use in the population increased by 0.4% after the intervention (0.2% before). The corresponding figure for patients with diabetes mellitus (treated with insulin or oral anti-diabetics) was 2.3% after the intervention (1.2% before), and for patients with CHD (treated with vasodilators) 8.1% after the intervention (5.0% before). Conclusion - Guidelines accompanied by a change in reimbursement rules had a significant influence on the prescribing of lipidlowering drugs. pubtype: Academic Journal doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|